Geode Capital Management’s Alzamend Neuro ALZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-39,152
| Closed | -$37.1K | – | 4447 |
|
|
2025
Q1 | $37.1K | Buy |
39,152
+5,612
| +17% | +$5.32K | ﹤0.01% | 4243 |
|
|
2024
Q4 | $38.9K | Buy |
+33,540
| New | +$38.9K | ﹤0.01% | 4281 |
|
|
2024
Q3 | – | Sell |
-52,397
| Closed | -$21.2K | – | 4537 |
|
|
2024
Q2 | $21.2K | Hold |
52,397
| – | – | ﹤0.01% | 4442 |
|
|
2024
Q1 | $52.4K | Hold |
52,397
| – | – | ﹤0.01% | 4310 |
|
|
2023
Q4 | $48.2K | Sell |
52,397
-583,613
| -92% | -$537K | ﹤0.01% | 4360 |
|
|
2023
Q3 | $151K | Buy |
636,010
+72,350
| +13% | +$17.2K | ﹤0.01% | 4092 |
|
|
2023
Q2 | $287K | Hold |
563,660
| – | – | ﹤0.01% | 3876 |
|
|
2023
Q1 | $240K | Hold |
563,660
| – | – | ﹤0.01% | 3952 |
|
|
2022
Q4 | $318K | Buy |
563,660
+37,910
| +7% | +$21.4K | ﹤0.01% | 3858 |
|
|
2022
Q3 | $625K | Buy |
525,750
+485,163
| +1,195% | +$577K | ﹤0.01% | 3611 |
|
|
2022
Q2 | $35K | Hold |
40,587
| – | – | ﹤0.01% | 4852 |
|
|
2022
Q1 | $49K | Buy |
40,587
+10,796
| +36% | +$13K | ﹤0.01% | 4806 |
|
|
2021
Q4 | $56K | Buy |
+29,791
| New | +$56K | ﹤0.01% | 4837 |
|
|
2021
Q3 | – | Sell |
-44,600
| Closed | -$389K | – | 4857 |
|
|
2021
Q2 | $389K | Buy |
+44,600
| New | +$389K | ﹤0.01% | 4052 |
|